EPI News 22.77 08/20/2014 05:02:21 India Earnings Wisdomtree

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
India Earnings Wisdomtree (EPI) 22.77 $EPI

Watch for WisdomTree India Earnings Fund to Potentially Pullback After Gaining 1.29% Yesterday
Comtex SmarTrend(R) - Mon Aug 11, 4:41PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $21.77 to a high of $22.00. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $21.87 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Shares of EPI Up 25.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Aug 07, 11:10AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 5 months, WisdomTree India Earnings Fund has returned 25.67% as of today's recent price of $21.76.

Uptrend Call Working As WisdomTree India Earnings Fund Stock Rises 26.5% (EPI)
Comtex SmarTrend(R) - Thu Jul 31, 9:55AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 5 months, WisdomTree India Earnings Fund has returned 26.54% as of today's recent price of $21.91.

31.2% Return Seen to Date on SmarTrend WisdomTree India Earnings Fund Call (EPI)
Comtex SmarTrend(R) - Thu Jul 24, 9:15AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 5 months, WisdomTree India Earnings Fund has returned 31.19% as of today's recent price of $22.72.

WisdomTree India Earnings Fund Rises 1.47% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 22, 5:25PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $22.67 to a high of $22.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $22.49 on volume of 5.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Decline of 2.21%, WisdomTree India Earnings Fund Offers Investors Better Value
Comtex SmarTrend(R) - Fri Jul 11, 5:00PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $21.60 to a high of $21.78. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $21.84 on volume of 4.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

29.0% Return Seen to Date on SmarTrend WisdomTree India Earnings Fund Call (EPI)
Comtex SmarTrend(R) - Wed Jul 09, 11:02AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 4 months, WisdomTree India Earnings Fund has returned 28.96% as of today's recent price of $22.33.

Bombay Easily Outpaces Asia's Exchanges In June
at Investor's Business Daily - Mon Jun 30, 4:30PM CDT
India's Bombay Stock Exchange continued to outrun stocks in China and Japan in June, climbing 4.9% for the month and rising 13.5% during the second quarter. But stocks in China and Japan fared far better in June than over the past quarter. The Nikkei...

WisdomTree India Earnings Fund Falls 1.44% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jun 26, 5:23PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $22.05 to a high of $22.20. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $22.07 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Bear Market for India ETFs Following Modi's Election? - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jun 19, 9:00AM CDT
Investors are facing a bear market in India ETFs following the election of Modi as Prime Minister.

Uptrend Call Working As WisdomTree India Earnings Fund Stock Rises 30.3% (EPI)
Comtex SmarTrend(R) - Tue Jun 17, 4:56PM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 3 months, WisdomTree India Earnings Fund has returned 30.29% as of today's recent price of $22.56.

'Fast Money' Recap: The Market Shrugs Off Iraq, for Now
at The Street - Sat Jun 14, 4:00AM CDT
The trading panel looked at Priceline's acquisition of OpenTable and what's going on with Groupon.

WisdomTree India Earnings Fund Falls 2.53% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Jun 13, 4:26PM CDT
WisdomTree India Earnings Fund (NYSE:EPI) traded in a range yesterday that spanned from a low of $22.26 to a high of $22.42. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $22.85 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

India Moves Beyond the 'BRICs' and Its ETFs Are Hot Again
at The Street - Tue Jun 10, 1:09PM CDT
India's economy, demographics and government are aligned for powerful growth

Shares of EPI Up 34.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jun 10, 11:02AM CDT
SmarTrend identified an Uptrend for WisdomTree India Earnings Fund (NYSE:EPI) on March 5th, 2014 at $17.32. In approximately 3 months, WisdomTree India Earnings Fund has returned 34.16% as of today's recent price of $23.23.

WisdomTree India Earnings Fund Experiences Big Inflow
ETFChannel.com - Mon Jun 09, 10:02AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the WisdomTree India Earnings Fund where we have detected an approximate $110.9 million dollar inflow -- that's a 8.3%...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles